Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1113 of 5804
-
AI-Powered home rehab aims to tame fibromyalgia pain
Symptom relief Not yet recruitingThis randomized controlled trial will evaluate the effectiveness of a 12-week, home-based telerehabilitation program for adults with fibromyalgia (FM) combining AI-guided exercise with Pain Neuroscience Education (PNE). Fifty participants will be randomized (1:1) to the digital i…
Phase: NA • Sponsor: Instituto Neurociencia Del Dolor • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Bladder cancer combo shows promise in Real-World review
Knowledge-focused Not yet recruitingThe ARON-2PLUS Study is designed as an International Multicentric Retrospective Study to collect global experiences with the use of Enfortumab vedotin plus Pembrolizumab as first-line therapy in patients with locally advanced/metastatic Urothelial Cancer. Two supplementary optio…
Sponsor: Aron Research Foundation Ets • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Zapping the brain to heal the liver: new trial tests TMS for fatty liver
Disease control Not yet recruitingThe goal of this clinical trial is to learn if repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive brain stimulation technique, works to treat Metabolic dysfunction-associated and alcohol-associated liver disease (MetALD). The main questions it aims to answer are:…
Phase: NA • Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
AI and wearables join forces to fight muscle loss in seniors
Knowledge-focused OngoingSarcopenia, the age-related decline in muscle mass and function, is a major contributor to frailty, disability, and mortality in older adults. Current diagnostic tools assess muscle quantity or function separately and lack predictive biomarkers, limiting early detection and perso…
Phase: NA • Sponsor: Tel Aviv University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New imaging technique could reveal how cancer drugs target tumors
Diagnosis Not yet recruitingAs a humanized bispecific antibody targeting PD-1 and VEGF-A, everolizumab exhibits high specificity for binding PD-1 and VEGF-A in vivo. This critical property was systematically validated in a recent molecular imaging study based on positron emission tomography (PET). The study…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Ultrasound-Enhanced gel and nerve stretching may ease diabetic foot pain
Symptom relief CompletedCerebral palsy is a neurological condition that affects movement, muscle control, and walking ability in children. Children with bilateral spastic cerebral palsy often experience increased muscle stiffness, difficulty with walking, reduced balance, and limited functional mobility…
Phase: NA • Sponsor: Syeda Khatoon e Jannat Welfare Foundation • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Cuff trick may help aging muscles grow without heavy lifting
Disease control CompletedThe purpose of this study was to learn if low-load resistance exercise combined with cyclical blood flow restriction (BFR) could improve small blood vessel structure and muscle size in older adults. Skeletal muscle thinning and the loss of tiny blood vessels (capillaries) common…
Phase: NA • Sponsor: Akdeniz University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New pill shows promise for frail elderly lymphoma patients
Disease control Not yet recruitingThis is a prospective, multicenter, phase II study, in elderly patients affected by Mantle cell lymphoma (MCL) defined as unfit/frail according to Simplified Geriatric Assessment (sGA) and previously untreated. Patients will receive a treatment with Pirtobrutinib monotherapy unt…
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New trick to tame prostate radiation: shrink the gland first!
Symptom relief Not yet recruitingThe goal of this clinical trial is to find out whether prostate artery embolization (PAE) can help prevent or lessen urinary side effects caused by radiotherapy (RT) in people with prostate cancer, especially those who have larger prostates or urinary symptoms before treatment. …
Phase: PHASE2 • Sponsor: Srinivas Raman • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can a computer diagnose depression as well as a doctor?
Diagnosis Not yet recruitingThe trial aimed to evaluate the accuracy of an artificial intelligence-based system for diagnosing depressive disorders. Specifically, it sought to determine whether the system's assessment validity is non-inferior to that of psychiatric specialists.
Sponsor: Shanghai Mental Health Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Could a Cottonseed-Derived drug help beat Chemo-Resistant colon cancer?
Disease control Not yet recruitingThis study is a single-center, single-arm clinical trial involving patients with TP53-mutated and LRPPRC-positive metastatic colorectal cancer. It aims to evaluate the efficacy and safety of gossypol acetate tablets combined with bevacizumab and the FOLFIRI regimen as a second-li…
Phase: PHASE2 • Sponsor: Guiying Wang • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New shot could cut stroke risk for High-Risk patients
Disease control Not yet recruitingThe research team is conducting a randomized, double-blind, placebo-controlled, multicenter clinical study aimed at evaluating the impact of adding Tolecilimab (a PCSK9 inhibitor) to standard lipid-lowering therapy (statins ± ezetimibe) on serum lipoprotein(a) \[Lp(a)\] levels an…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Heart shield: common drug may prevent Chemo-Induced cardiac harm
Prevention Not yet recruitingThis study aims to evaluate the efficacy and safety of telmisartan as a cardioprotective agent in patients receiving doxorubicin-based chemotherapy, with the goal of reducing treatment-associated cardiotoxicity, optimizing therapeutic outcomes, and facilitating the safer administ…
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Gut bacteria pill could turn back the clock on aging
Disease control Recruiting nowThis study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores…
Phase: NA • Sponsor: Synbiotic Health • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Brain pacemaker gets smarter to stop freezing in Parkinson's
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if adaptive deep brain stimulation (DBS) can decrease or prevent freezing of gait in participants with Parkinson's disease.
Phase: NA • Sponsor: Doris Wang, MD, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New study aims to stop postpartum bleeding in At-Risk moms
Prevention Not yet recruitingPostpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide, particularly among women with known risk factors. Uterotonic agents are routinely administered after vaginal delivery to prevent excessive bleeding. Carbetocin, a long-acting oxytocin an…
Phase: NA • Sponsor: Western Galilee Hospital-Nahariya • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
ER iron infusion could get anemic kids home faster
Symptom relief Not yet recruitingThe goal of this project is to assess the feasibility, clinical effectiveness, and cost-effectiveness of IV iron therapy using ferric carboxymaltose (FCM) as a treatment for pediatric patients with iron deficiency anemia (IDA) in the emergency department (ED). The primary object…
Phase: PHASE4 • Sponsor: Children's Hospital of Orange County • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Could a single chemo drug replace the standard doublet for some ovarian cancers?
Disease control Not yet recruitingPlatinum-based neoadjuvant chemotherapy (NACT) followed by interval debulking surgery is a crucial treatment paradigm for advanced ovarian cancer. It can reduce tumor burden, increase the rate of R0 resection, and decrease surgical complications. The combination of paclitaxel and…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Weekly shot may beat daily shots for blood recovery after transplant
Disease control Recruiting nowThis study is for adults aged 18-65 with myelodysplastic syndrome (MDS) or severe aplastic anemia (AA) who are scheduled to receive a donor stem cell transplant (allogeneic hematopoietic stem cell transplant). After the transplant, it is critical for the body to start making its …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New rabies shot could shield millions after bites
Prevention Not yet recruitingA Phase II, Single-Center, Randomized, Blinded, Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody Injection in Healthy Subjects
Phase: PHASE2 • Sponsor: Lanzhou Institute of Biological Products Co., Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC